News & Analysis as of

Court of Justice of the European Union (CJEU) China

WilmerHale

FRAND Quarterly: Navigating the Global SEP Landscape - May 2025

WilmerHale on

The beginning of 2025 saw two overarching trends in FRAND litigation...more

Eversheds Sutherland (US) LLP

Updata: Your quarterly Data Privacy and Cybersecurity update - October - December 2020

Updata is an international report produced by Eversheds Sutherland’s dedicated Privacy and Cybersecurity team – it provides you with a compilation of key privacy and cybersecurity regulatory and legal developments from the...more

Hogan Lovells

Covid-19 IP Update: Intellectual Property Office developments (UPDATED)

Hogan Lovells on

China - On 28 January 2020, CNIPA (China's National Intellectual Property Administration) published its Notice 350, which is applicable to both trademark and patent matters....more

Hogan Lovells

Covid-19 IP Update: Intellectual Property Office developments (UPDATED)

Hogan Lovells on

EUIPO - For those with European Union Trademarks (EUTMs), the European Union Intellectual Property Office (EUIPO) in Alicante, Spain remains open although all staff are now working from home and it has extended all deadlines...more

Hogan Lovells

Covid-19 IP Update: Impact on litigation (UPDATED)

Hogan Lovells on

France - By an implementation regulation issued on 16 March 2020, the Ministry of Justice has declared the closure of the courts, except for criminal and civil emergency services. This measure involves both the suspension of...more

Hogan Lovells

The Foreign Investment Regulation Review Seventh Edition - EU Overview

Hogan Lovells on

Foreign investment continues to garner a great deal of attention. This trend is expected to continue as the global economy further integrates, the number of cross-border and international transactions keeps increasing, and...more

American Conference Institute (ACI)

[Event] Pharmaceutical Patent Term Extensions – The Only Specialized Forum on SPCs and Patent Protection in Europe and Around the...

This year’s C5’s Pharma Patent Term Extensions Forum arrives at a critical time for the pharmaceutical industry. Overarching developments from the Teva U.K. decision (C-121/17) to the SPC Manufacturing Waiver and the most...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide